Connection (CNXN) Reports Record First Quarter 2022 Results
FIRST QUARTER HIGHLIGHTS: Net sales: $788.3 million, up 23.8% y/y Gross profit: $128.3 million, up 27.6% y/y Net income: $21.8...
Month: May 2022
Axonics® Reports First Quarter 2022 Financial Results
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the...
NeoGenomics To Participate in the BofA Securities 2022 Healthcare Conference
FT MYERS, FL / ACCESSWIRE / May 5, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing...
UPDATED RELEASE: Jaguar Health to Host Investor Webcast Tuesday, May 10th at 8:30 AM Eastern Time Regarding Q1 2022 Financials & Corporate Updates
Click here to register for webcastCompany plans to file its Earnings Report on May 10, 2022 on Form 10-Q for...
TimelyMD Recognized for Virtual Care Innovation in 2022 MedTech Breakthrough Awards Program
Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies FORT WORTH, Texas--(BUSINESS WIRE)--#digitalhealth--MedTech Breakthrough, an independent market...
Zelis Named “Best Overall Digital Health Company” in 2022 MedTech Breakthrough Awards Program
Annual Awards Program Recognizes Outstanding Health & Medical Technology Leadership Across Industry BEDMINSTER, N.J.--(BUSINESS WIRE)--MedTech Breakthrough Awards today named Zelis,...
World Leader in De-Escalation Training and Workplace Violence Prevention Honors All Health Care Workers During May’s National Nurses and National Hospital Weeks
Crisis Prevention Institute also providing free resource of tips on de-escalating situations before they get out of controlMILWAUKEE, WI /...
Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon Canada
First commercial launch of nutraceutical products in North American MarketCHICAGO, IL / ACCESSWIRE / May 5, 2022 / Cosmos Holdings,...
Altamira Receives Regulatory Approval from the Ministry of Health to Expand COVAMID Trial for Bentrio in Acute COVID-19 into North Macedonia
Extending clinical study will complement the ongoing trial in BulgariaReaffirms it expects to complete the study in 3Q-22 subject to...
Biotricity Issues Shareholder Update
Company highlights recent achievements and strategic initiatives setting the foundation to drive revenue growth to record levels in calendar 2022National...
Jaguar Health to Host Investor Webcast Tuesday, May 10th at 8:30 AM Eastern Time Regarding Q1 2022 Financials & Corporate Updates
Click here to register for webcastCompany plans to file its Earnings Report on May 10, 2022 on Form 10-Q for...
Gemina Labs Completes Successful Human Clinical Performance Evaluation on its Legio X COVID-19 Rapid Antigen Test
VANCOUVER, BC / ACCESSWIRE / May 5, 2022 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is pleased to...
Health Karma(R) Selected by Salon Spa Professional Association to Provide Virtual Health Benefits
FORT LAUDERDALE, FL / ACCESSWIRE / May 5, 2022 / MediXall Group Inc. (OTCQB:MDXL) ("MediXall"), an innovative healthcare solutions provider,...
9 Meters Biopharma to Present at the H.C. Wainwright Global Investment Conference and the LifeSci Partners Immunology & Inflammation Symposium
RALEIGH, NC / ACCESSWIRE / May 5, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments...
Apollon Acquires Intellectual Property from Aion
LONDON, UK / ACCESSWIRE / May 5, 2022 / Apollon Formularies plc (AQSE:APOL) ("Apollon" or the "Company"), a UK based...
Lumos Pharma Announces a Clinical Collaboration with Massachusetts General Hospital (MGH) to Evaluate Oral LUM-201 in Nonalcoholic Fatty Liver Disease (NAFLD) in a Phase 2 Investigator-Initiated Trial
The IND application for this pilot trial to evaluate oral growth hormone secretagogue, LUM-201, in NAFLD has been approved by...
Cassava Sciences Reports First Quarter Financial Results for 2022 and Updates on Phase 3 Clinical Program
- $209.7 Million Cash and Cash Equivalents at March 31, 2022 – - Over 120 Patients Now Enrolled in Phase...
Eko Recognized with Second Consecutive MedTech Breakthrough Award for AI Innovation in Healthcare
Point-of-care cardiac screening solution honored at sixth annual awards program for improving detection of heart disease Eko MedTech Breakthrough Award...
Turning Point Therapeutics Announces Pipeline Expansion, Licensing of TPX-4589 (LM-302), A Clinical Stage Anti-Claudin18.2 Antibody Drug Conjugate for Gastrointestinal Cancers, From Lanova Medicines
Strategic Expansion of Turning Point Precision Oncology Portfolio TPX-4589 (LM-302) Currently in Two Ongoing Phase 1 Studies Agreement Includes Potential...
Myriad Genetics Reports First Quarter Revenue and Reiterates Guidance for 2022
Highlights: Revenue of $164.9 million for the quarter ended March 31, 2022 Excluding revenue from divested businesses, revenue increased 11%...